| scholarly article | Q13442814 |
| P356 | DOI | 10.1158/1055-9965.EPI-06-0777 |
| P698 | PubMed publication ID | 17301263 |
| P2093 | author name string | Pentti Tuohimaa | |
| Matti Hakama | |||
| Timo Hakulinen | |||
| Joakim Dillner | |||
| Sonja Lumme | |||
| Heimo Syvälä | |||
| Leena Tenkanen | |||
| P433 | issue | 2 | |
| P921 | main subject | prostate cancer | Q181257 |
| metabolic syndrome | Q657193 | ||
| P304 | page(s) | 302-307 | |
| P577 | publication date | 2007-02-01 | |
| P1433 | published in | Cancer Epidemiology, Biomarkers & Prevention | Q326334 |
| P1476 | title | Interaction of factors related to the metabolic syndrome and vitamin D on risk of prostate cancer | |
| P478 | volume | 16 |
| Q46981314 | Association between metabolic syndrome, diabetes mellitus and prostate cancer risk |
| Q34228158 | Associations of circulating 25-hydroxyvitamin D with prostate cancer diagnosis, stage and grade |
| Q42371605 | BMI and serum lipid parameters predict increasing risk and aggressive prostate cancer in Chinese people |
| Q34132305 | Bone marrow fat: linking adipocyte-induced inflammation with skeletal metastases |
| Q38088550 | Effect of metabolic syndrome and its components on prostate cancer risk: meta-analysis |
| Q37622507 | Epidemiology of vitamin D in health and disease |
| Q38132333 | High-density lipoprotein and prostate cancer: an overview |
| Q37166965 | Hypertension and risk of prostate cancer: a systematic review and meta-analysis |
| Q37385840 | Hypertension, obesity and prostate cancer biochemical recurrence after radical prostatectomy. |
| Q39145052 | Meta-analysis of metabolic syndrome and prostate cancer. |
| Q37842886 | Meta-analysis: Circulating vitamin D and ovarian cancer risk |
| Q36334568 | Metabolic syndrome and risk of cancer: a systematic review and meta-analysis |
| Q42757693 | Metabolic syndrome and urologic diseases |
| Q33921635 | Metformin and longevity (METAL): a window of opportunity study investigating the biological effects of metformin in localised prostate cancer |
| Q48346823 | Midlife metabolic factors and prostate cancer risk in later life |
| Q33992150 | Plasma vitamin D and prostate cancer risk: results from the Selenium and Vitamin E Cancer Prevention Trial |
| Q53144362 | Positive association between circulating 25-hydroxyvitamin D levels and prostate cancer risk: new findings from an updated meta-analysis. |
| Q37248315 | Racial differences in risk of prostate cancer associated with metabolic syndrome |
| Q35286318 | Serum 25-hydroxy vitamin D and prostate cancer risk in a large nested case-control study |
| Q36407365 | Serum total and HDL cholesterol and risk of prostate cancer |
| Q35390159 | The Metabolic Syndrome and Biochemical Recurrence following Radical Prostatectomy. |
| Q87052371 | Vitamin D Deficiency Adds an Element of Risk to Insulin Resistance in Colorectal Neoplasms |
| Q26766256 | Vitamin D and Colorectal, Breast, and Prostate Cancers: A Review of the Epidemiological Evidence |
| Q39658509 | Vitamins, metabolomics, and prostate cancer |
Search more.